Telemedicine may help identify & treat DR

Article

With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathway to ensuring that more patients receive care, and thus, prevent complications from retinopathy.

With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathway to ensuring that more patients receive care, and thus, prevent complications from retinopathy, said P. Lloyd Hildebrand, MD, Dean A. McGee Eye Institute, Oklahoma University Health Sciences Center, US.

“Remote retinal imaging with centralized interpretation allows for increased access, quality, and efficiency,” he said. This is especially true for a largely rural population.Putting together a telemedicine programme is not easy, however, Dr Hildebrand said. He offered a 10-step approach:

1. Decide whether you want to target detection or diagnostic evaluation. This knowledge will affect the protocols and technologies you’ll implement.2. Plan to measure the quality of your efforts through five parameters: reproducibility, technical referral rate, number of ungradeable eyes, accuracy, and compliance.3. Develop a viable business model. “This may be the biggest problem to developing a program, especially in the United States,” Dr Hildebrand said. “Margins are tight, and you're dealing with highly variable health plan reimbursement policies.”4. Generate useful reports.5. Push compliance. Programmes that drive compliance, such as disease registries and call systems, will be important.6. Educate, educate, educate. Because much of diabetes is a primary care disease, enlist the help of primary care physicians to inform patients about the seriousness of diabetic retinopathy and to encourage them to participate.7. Plan for the outliers - you will encounter patients who have other pathologies.8. Provide a solution; have an outlet to provide treatment.9. Understand the barriers, whether those are geographical, governmental, or something else.10. Understand that many questions about retinopathy remain to be answered.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.